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The inhibition of antibody formation by antimetabolites has been reported 
in some species. Schwartz et al. demonstrated the suppression  of antibody re- 
sponse to bovine serum albumin in rabbits employing 6-mercaptopurine (1); 
8-azaguanine  has been found to decrease hemolysin and precipitin production 
in mice (2). In vitro antibody synthesis has been blocked by amino acid ana- 
logues (3), 8-azaguanine  (4), or 5-bromouracil  deoxyriboside  (5). 
That  aminomethylpteroylglutamic acid  (methotrexate) might  inhibit  im- 
munologic responses has been suggested by several lines of investigation. Folic 
acid deficiency has been found to impair antibody production in rats  (6,  7) 
and chicks (8). Haas et al., using methotrexate in mice, noted modification of 
normal LCM  ~ virus-host and tumor-host relationships (9-12).  Other work in 
mice indicates that methotrexate decreases mortality due to homograft reac- 
tions following lethal total body x-irradiation and homologous marrow inocu- 
lation (13). 
Recent publications have reported the development of a  form of delayed 
skin reactivity following  injection of small amounts of protein antigens in 
Freund's adjuvant (14), and that this reaction is diminished, but not completely 
suppressed,  in guinea pigs by 200 r total body x-irradiation (15). Development 
of the delayed sensitivity is followed by production of antibody, a  response 
which is suppressed by 200 r total body x-irradiation (15, 16). A definite rela- 
tionship between the development of delayed sensitivity and the initiation of 
production of antibody has not been established. 
The present paper describes  the suppression  in guinea pigs of both the de- 
layed response  and antibody production by administration of methotrexate. 
LCM, lymphocytic  choriomeningitis. 
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Methods and Materials 
Animals.--Gninea pigs were 200 to 300 gm male Hartley albinos. 
Reagents.--The  NIH standard diptheria toxoid was employed for sensitization. For skin 
testing, Massachusetts Department of Health purified diphtheria toxoid, lot KP59a (50 Lf/cc, 
1730 Lf/mg N) obtained through the courtesy of Dr. James A. McComb, was used. Ovalbumin, 
5X recrystallized,  was  obtained from  Nutritional Biochemical  Corporation,  Cleveland.  A 
lyophilized heat-killed preparation of BCG tuberculoprotein and rabbit antihuman gamma 
globulin were provided by  Dr.  H.  Baer  of  the  Division of  Biologics  Standards,  National 
Institutes of Health. Human gamma globulin was obtained, courtesy of the American Red 
Cross,  and  4-amino-NXO-methylpteroylglutamic acid  was  purchased  as  methotrexate  from 
Lederle Laboratories Division of American Cyanamid, Pearl River, New York. 
Sensitization.--Guinea  pigs were injected in their foot-pads with a  total of 1 Lf of toxoid 
or 3 #g ovalbumin in 0.4 cc of equal volumes of buffered saline and either Freund's incomplete 
adjuvant (8.5 parts of bayol F, 1.5 parts arlacel A) or Freund's complete adjuvant (incomplete 
+  4 mg BCG tuberculoprotein per animal). 
Skin Testing.--Animals  were injected intradermaUy with 0.1 ml containing 25/zg of oval- 
bumin or 5 Lf of diphtheria toxoid. Tests were read at 6 and 24 hours and recorded as the 
diameters of  erythema and induration in millimeters. Reactions greater  than 10  mm  in 2 
diameters were consider positive. 
Determination of Presence of Antibody.--For  elidting systemic anaphylaxis an intravenous 
injection of 0.25 cc of a 4 mg/ml solution of ovalbumin was employed. Active cutaneous ana- 
phylaxis (ACA)  (17)  was performed by intradermal injection of 25/~g of either diphtheria 
toxoid or ovalbumin following injection of 0.25 ml of 2 per cent Evan's blue intravenously. 
20 minutes after inoculation of the antigen, animals were sacrificed and skin sites examined 
for relative accumulation of dye as compared to control sites injected with 25/~g of the heter- 
ologous antigen. Dye accumulations greater than 10 mm in diameter were considered positive. 
Guinea pigs were tested for antibody to diphtheria toxin by a toxin neutralization test. Animals 
were injected with dilutions of a standard toxin and skin sites read at 42 hours. In all eases, 
only one test was performed per animal and animals were either skin-tested or examined for 
antibody. 
Recording  of Temperature.--Rectal  temperatures  of animals, inoculated with antigen in 
complete adjuvant as previously  indicated  and, after  7 days,  injected  intraperitoneally  with 
4 mg of antigen,  were determined as described  by Uhr (18). 
Hisldogic  and  Blood  Studies.--White blood cell  (WBC) counts were  determined  in  a Levy 
hemocytometcr. Wright's stained  smears were examined for  differential  counts.  Hemoglobin 
was determined in a Sahli  hemoglobinometer. Skin sections  were stained  with hematoxylin 
and  cosin  and  examined  with  the  assistance  of  Dr.  Ruth  Kirschstcin  of  the  Division  of  Biologics 
Standards, National Institutes  of Health. 
Methotrexate  Dose Schedules.--Animals  were  injected  intraperitoneally  every  48  hours 
with 1.7 mg or 5 mg of  methotrexate in 1 cc of Ringer's solution. Controls received 1 ec of 
Ringer's solution by  the same  route.  Treatment  was  started 2  days  before inoculation of 
antigen. 
RESULTS 
Systemic  Effect of Methotrexate in Guinea Pigs.--All guinea pigs in the ex- 
periments described  survived 14 days administration of the  1.7 mg or 5 mg 
dose schedules of methotrexate. Animals lost about 10 per cent of their original 
body weight during the first 4 days of administration of the drug, but by 1 ]~'RIEDM.AN~ BUCKLER~ AND  BARON  175 
TABLE  I 
Effect of Metkotrexate on Skin Reactions of Guinea Pigs Injected with 1 Lf of Dipktkeria  Toxoid 
in lncomflete Adjuvant 
Size (ram) of skin reaction at 6 and 24 hours following skin test.* 
Not treated  Methotrexate-treated 
Day after 
immunization 
6 hrs.  24 hrs.  6 hrs. 
12 
14 
25  X  20 
20  X  15 
19  X  12 
40  X  30 
35  X  30 
30  X  30 
35  X  20 
30  X  20 
25  X  15 
25  X  20 
19  X  15 
18  X  14 
17  X  14 
16  X  11 
14  X  12 
30  X  28 
30  X  28 
25  X  20 
25  X  18 
22  X  20 
20  X  17 
20  X  15 
20  X  12 
20  X  12 
19  X  18 
19  X  17 
17  X  15 
17  X  10 
15  X  10 
0 
o~ 
0 
0 
0 
0 
0 
25  X 
24 hrs. 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
23  0 
0 
0 
0 
* All animals skin-tested with 5 Lf toxoid in 0.1 cc. 
Reactions of less than 10 mm are reported as 0, as animals inoculated with heterologous 
antigen had reactions up to this size when tested with toxoid. 176  SKIN  HYPERSENSITIVITy  AND  ANTIBODY  FORMATION 
week they were back to their original weights;  thereafter,  there was a  weight 
gain. During the period of methotrexate administration WBC counts and hemo- 
globins were  stable  while  differential  WBC  counts  changed from 66 per  cent 
lymphocytes before  drug  administration  to  90 per  cent  after  2  weeks;  poly- 
morphonuclear  counts  dropped  from  34  to  10  per  cent  during  this  period. 
TABLE II 
Effect of Methotrexate on Skin Reactions of Guinea Pigs Injected  with 3 ~g of Ovalbumin in 
Incomplete Adjuvant 
Size of skin reaction at 6 and 24 hours following skin test* 
Not treated  Methotrexate-treated 
Day after 
immunization 
6 hrs.  24 hrs.  6 hrs.  24 hrs. 
* All animals 
22  X  20 
20  X  20 
16  X  15 
10  X  10 
30  X  20 
25  X  20 
25  X  20 
22  X  20 
20  X  18 
25  X  20 
25  X  19 
20  X  16 
20  ×  15 
0 
0 
0 
0 
0 
0 
0 
kin-tested with 25/zg ovalbumin. 
0 
0 
0 
0 
0 
0 
Paper  electrophoretic  studies  of serum protein levels of experimental  animals 
failed to demonstrate  any consistent changes during  the course of the experi- 
ments.  These results  are in general agreement with  a  report  that  guinea pigs 
are relatively insensitive to the toxic effects of methotrexate  (19). 
Effect  of Methotrexate  on  Skin  Reactions  Employing  Antigens  in  Incomplete 
Adjuvant.--When  animals  were  inoculated  with  diphtheria  toxoid  in  incom- 
plete  Freund's adjuvant  and skin-tested  up to 2  weeks following injection  of 
the homologous antigen, delayed reactions were noted on days 5 to 7 following 
inoculation  (Table  I).  Mter 9  days, Arthus reactions  (6 hours)  were  seen.  In FRIEDM.A/q,  BUCKLER, AND BARON  177 
contrast,  only 1  of the  methotrexate-treated animals which  was  inoculated 
with toxoid in adjuvant developed a  skin reaction to  toxoid greater in size 
than controls inoculated with a heterologous antigen (ovalbumin). 
In order to confirm these results, a  test system employing another antigen, 
ovalbumin, was used. Table II shows results seen in this system when animals 
were tested on days 5 to 7. The animals receiving methotrexate did not develop 
delayed reactions during this period. 
Effect of Methotrexate  on Antibody Production  Using Antigens in Incomplete 
Adjuvant.--14 days after inoculation with ovalbumin or diphtheria toxoid in 
incomplete adjuvant, animals were tested for antibody by various means. To 
test for antibody to diphtheria toxin, two methods were employed: either ACA 
which has been reported by Uhr to be positive in cases where passive cutaneous 
anaphylaxis and the  toxin neutralization test in rabbits  have been negative 
TABLE III 
Effect of Methotrexate on Antibody Formation in Guinea Pigs Injected with 1 L/of Dipktheria 
Toxoid in Incomplete Adju~ant 
Test for antibody  Not treated  Methotrexate-treated 
Active cutaneous  anaphylaxis  (ACA)  3/3*  0/6 
Toxin neutralization  8/9  0/15 
* Reported as: Number positive for antibody over total tested. All animals tested on the 
14th day following  immunization. 
(15); or toxin neutralization in the skin of the guinea pig being tested for anti- 
body. This test will detect as little as 3.5 X  10-5 units of antitoxin when the 
minimum dose of standardized toxin which gives a  positive  reaction is used 
(20).  Results of these tests for antibody are reported in Table III. Diphtheria 
antitoxin was not detected by either test in animals receiving methotrexate 
whereas it was found in all but 1 of the control animals. 
In order to test for antibody to ovalbnmln, systemic anaphylaxis and ACA 
were employed. In addition, controls to indicate whether methotrexate itself 
could  inhibit  anaphylaxis  were  included.  Animals were,  therefore,  injected 
with ovalbumin in incomplete adjuvant and given 1.7 mg of methotrexate 2 
days before being tested; also, animals inoculated with ovalbumin in adjuvant 
and given a  complete 2 week, 1.7 mg course of methotrexate, were passively 
sensitized with rabbit antihuman gamma globulin serum 12 days after primary 
injection and 2 days later challenged with human g~mma globulin. Results are 
shown in Table IV. Again, none of the animals receiving methotrexate were 
positive in tests for antibody. Among controls, all animals were found to have 
antibody. Systemic anaphylaxis occurred in passively sensitized animals which 
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Effect of Methotrexate  on Skin Reactions and on Antibody Production Employ- 
ing  Toxoid  in  Complete  Adjuvant.--Unlike  the  results  seen when incomplete 
adjuvant was employed, animals inoculated with toxoid in complete adjuvant 
developed delayed hypersensitive reactions to  toxoid despite  treatment with 
the 1.7 mg regimen of methotrexate (Table V). In most of the animals, how- 
ever, this dose of methotrexate was sufficient to block the antibody response 
as determined by ACA  tests.  These findings resemble those in studies of ir- 
radiated animals  in which antibody production, but not delayed hypersensi- 
tivity, was blocked (15,  16). 
TABLE  IV 
Effea of Methotrexate on Antibody Formation in Guinea Pigs Injected with 3 tzg of Ovalbumin 
in Incomplete Adjuvant 
Treatment 
None 
Methotrexate§ 
Methotrexate on 12th day only 
Methotrexate  +  rabbit  anti- 
human gamma globulin  on day 
12§ 
Test on 14th day after immunization 
i.v., ovalbumin or ACA 
i.v., ovalbumin or ACA 
i.v., ovalbumin 
i.v., human gamma globulin 
Results 
Fraction 
showing 
fatal ana- 
phylaxis* 
3/3 
0/6 
3/3 
3/3 
Fraction 
showing 
ACM 
3/3 
0/6 
* Reported as fatal reaction/total  tested. 
:~ Reported as positive ACA/total tested. 
§ 1.7 mg methotrexate every 48 hours commencing  2 days before immunization. 
In order to determine whether delayed skin reactivity following injection of 
antigen in complete Freund's adjuvant could be blocked by methotrexate, an 
experiment was performed using a  dose schedule of 5 mg of the drug every 48 
hours. Table VI shows the results of skin tests with toxoid in these animals. 
The larger dose of methotrexate was sufficient to inhibit the development of a 
delayed skin reaction and of antibody production following inoculation with 
toxoid in complete adjuvant. Histologic studies of skin test sites in this experi- 
ment  showed  that  sections  from animals  given  methotrexate  were  indistin- 
guishable microscopically from untreated controls tested with a  heterologous 
antigen  (ovalbumin), while controls tested with homologous antigen  (toxoid) 
had marked mononuclear infiltrates. 
Specific Febrile Response.--Uhr has shown that guinea pigs develop a specific 
febrile response when they are inoculated intraperitoneally with a large amount 
of an antigen to which they have a  delayed hypersensitive response  (18).  In 
order to determine whether methotrexate would block this response a  group TABLE  V 
Effect of 1.7 Mg Methotrexate Regimen on Skin Reactions and Antibody  Response in Guinea 
Pigs Injected with 1 Lf of Diphtheria Toxoid in Complete Adjuvant 
Day after 
immunization 
14 
Test 
Skin test, diphtheria toxoid, 5 Lf 
ACA, for diphtheria antitoxin 
Size of skin reaction at 24 hrs.* 
Not treated 
mm 
35  X  23 
30  X  25 
27  X  25 
25  X  25 
25  X  20 
22  X  17 
22  X  17 
20  X  18 
20  X  17 
15  X  11 
Methotrexate-treated 
mm 
32  X  28 
22  X  20 
20  X  15 
20  X  12 
18  X  17 
17  X  14 
15  X  12 
13  X  13 
0 
0 
Results of ACA 
5/6~  1/6 
* Animal skin-tested with 5 Lf of toxoid in 0.1 cc. 
:~ Reported as number positive for ACA over total tested. 
TABLE  VI 
Effect of 5 Mg Methotrexate Regimen on Skin Reactions and Antibody Response in Guinea Pigs 
Sensitized with 1 Lf  f Diphtheria ToxMd in Complete Adjuvant 
Test 
Skin  test,  toxoid  5 
Lf 
Day after 
immunization 
ii 
15 
16  ACA for antitoxin 
Size of skin reaction 
Not treated  Methotrexate-treated 
6 hrs.  24 hrs.  24 hrs. 
mm 
0 
0 
0 
0 
0 
35  X  20 
30  X  20 
25  X  19 
mm 
22 X  20 
22 X  18 
20 X  17 
20 X  15 
20 X  12 
17 X  10 
15 X  13 
0 
6  hrs. 
mm 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
mm 
O* 
0 
0 
0 
0 
Results of ACA test 
6/7~  0/3~ 
* Reactions of less than 10 mm are reported as 0, as animals inoculated with heterologous 
antigen had reactions up to this size when tested with toxoid. 
:~ Reported as number positive for ACA over total tested. 
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of 5 animals was inoculated with ovalbumin in complete  Freund's adjuvant, 
treated with the 5 mg regimen of methotrexate, and 7 days after inoculation, 
when delayed reactivity is strong,  given  a  4 mg intraperitoneal injection of 
ovalbumin. The results of this experiment are illustrated in Fig. 1. A group of 
6 untreated control animals specifically challenged with ovalbumin responded 
with a temperature rise as reported by Uhr (18). Animals given methotrexate 
and challenged with homologous antigen (ovalbumin)  had small temperature 
rises similar to the pattern of 10 control animals challenged with 4 mg of heter- 
ologous antigen--5 human gamma globulin-sensitized animals were tested with 
2_0 
1.5 
hO 
a5 
I  i  I  I  I 
Sensitive  to : 
Ovnlbumin 
o) Ovalbutain 
A--A  or 
b) Human  )'-Globulin 
q)~qP  Ovolbumin 
1  I  I  t  I 
I  2  3  4  5 
Treatment  Challeno~  withn 
None  Ovolbumin 
None  a)  Human y-Globulin 
'or 
None  b)  Ovolbumin 
Methotrexate  Ovolbumin 
TIME  AFTER  INTRAPERITONEAL  INJECTION- HOURS 
Fro. 1.  Specific febrile response in methotrexate-treated guinea pigs. 6 ovalbumin-sensitive 
positive controls were challenged intraperitoneally with 4  mg of ovalbumin.  5 animals were 
inoculated with ovalbumin, treated with the 5  mg regimen of methotrexate, and challenged 
with 4  rag of ovalbumin and 10 negative controls, sensitized with either ovalbumin or human 
3' -globulin, were challenged with the  heterologous antigen.  The average temperature  ele- 
vations of the three groups are shown. Test was performed 7 days after primary inoculation. 
4 mg of ovalbumin,  and 5 ovalbumin-sensitized  animals,  with human gamma 
globulin. 
Similar results have been found employing toxoid. 
DISCUSSION 
The effects of methotrexate on the immunologic responses  of guinea pigs 
apparently depend upon the strength of the antigenic stimulus and upon the 
dose of methotrexate employed. Suppression of the delayed response following 
injection of antigen in complete  adjuvant requires  more of the drug than is FRIEDMAN, BUCKLER, AND BARON  181 
needed to suppress the delayed response following inoculation with antigen in 
incomplete adjuvant. The antibody response is more easily inhibited in guinea 
pigs by methotrexate than is the delayed hypersensitive response.  In this re- 
spect the effect of methotrexate resembles that of x-irradiation(15,  16). 
It is interesting to note that methotrexate does not seem to inhibit immuno- 
logic reactions in rabbits (21), a finding which may be analogous to the situa- 
tion  which  exists  with  8-azaguanine  which  inhibits  antibody  production  in 
mice,  but not in rats  (2).  These differences  in drug sensitivity may relate to 
species  differences  in  susceptibility of enzymes to methotrexate,  to  the rate 
of detoxication of methotrexate,  or to any of several other possible explana- 
tions (19). 
The  exact mechanism  by which methotrexate  suppresses immunologic  re- 
sponses in guinea  pigs is obscure, as folic acid derivatives are important  in 
many  biochemical processes  (22),  and  methotrexate  acts  as a  folic  acid in- 
hibitor  (19).  Since, however, the synthesis of a  new protein  (here,  antibody) 
involves formation of nucleic acid, it is of significance  that methotrexate in- 
hibits  nucleic acid synthesis.  Schwartz  postulated  that  inhibition  of nucleic 
acid synthesis may be the basis for the action of 6-mercaptopurine to depress 
antibody formation  in  rabbits  (1).  The  fact  that  delayed sensitivity is not 
completely suppressed in guinea pigs by an LD60 of x-irradiation  (15) may be 
due to the relative radioresistance of the biochemical processes for nucleic acid 
synthesis (23). 
Suppression of the development of the delayed hypersensitive state might 
be a useful tool in the investigation of such biological phenomena as the mecha- 
nism for antibody synthesis  (24),  autoimmunity,  the rejection of homografts 
(25), and the host reaction to infection (26). The observation that methotrexate 
inhibits the specific febrile response in addition to inhibiting  the delayed skin 
reaction, may indicate that methotrexate acts to suppress development of the 
delayed sensitive state and not simply delayed skin reactivity. 
SI3"~ARY 
1. In guinea pigs,  aminomethylpteroylglutamic acid (methotrexate)  is cap- 
able of blocking the development of delayed skin hypersensitivity, the primary 
antibody response, and  the  specific febrile response to ovalbumin and  diph- 
theria toxoid. The primary antibody response is more easily inhibited than is 
the development of delayed skin hypersensitivity. 
2. The effect of methotrexate on immunologic  responses depended upon the 
dose of methotrexate employed and the strength of the antigenic stimulus. 
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